Recent sea changes in the healthcare industry have set in motion new market dynamics that drive the demand for more transparency and deeper understanding of prices for healthcare products and services. An environment has been created, by enactment of the Healthcare Price Transparency Act of 2012, which places an emphasis on the availability of price information for all healthcare products and services. Because of the growing pressures on healthcare budgets, appropriate justification for current expenditures and future investments in healthcare services are becoming increasingly important. Copharix was formed to address the need for independent assessments of healthcare market trends. Initially, Copharix will provide its analytics services and software to pharmaceutical companies, insurers, pharmacy benefit managers and other participants in the pharmaceutical value chain. Copharix will produce pharmacoeconomic data and analytics that help to characterize healthcare prices and other important industry metrics. The use of pharmacoeconomic analyses to support drug cost reimbursement decision-making is a central focus of Copharix. We expect to offer value added, independent, analysis of critical elements of healthcare market dynamics.
The Copharix Team has broad, interdisciplinary experience and expertise in various industries including sectors of the healthcare market. The Copharix Team has extensive experience and expertise in business intelligence, pharmaceutical value chain analysis, and other disciplines that enable us to provide guidance regarding key planning, operational and strategic decisions.